Bull's-Eye Maculopathy in a Patient with Lupus

Kristina Lou; Christopher Forest

Bull's-Eye Maculopathy in a Patient with Lupus

Kristina Lou, Christopher Forest

California State University, Monterey Bay

Research output: Contribution to conference › Presentation

Abstract

CHIEF COMPLAINT:

49 yo male visualizes a “yellow donut hole” in his central vision x one year. He notes impaired night vision and difficulty focusing on individual letters. He denies eye pain, diplopia, headache, photophobia, sensory or motor deficits. This case may have been related to hydroxychloroquine toxicity.

DISCUSSION:

Bull’s-eye maculopathy signifies irreversible damage, which may continue to progress months following discontinuing the medication.

The American Academy of Ophthalmology recommends: Baseline retinal screening within the first year of treatment and an Annual follow-up screening after 5 years.

Original language	American English
State	Published - May 2016
Event	American Academy of Physician Assistants / 40th Annual PA Conference - San Antonio, TX Duration: May 1 2016 → …

Conference

Conference	American Academy of Physician Assistants / 40th Annual PA Conference
Period	5/1/16 → …

Keywords

Bull's Eye
Lupus complication
Maculopathy
Ophthalmology

Disciplines

Medicine and Health Sciences

Access to Document

201600081 Lou Forest BullsEye Maculopathy.pdfFinal published version, 274 KBLicense: Unspecified

Cite this

@conference{4192bb66e6724b91b15d7b52eddf5abe,

title = "Bull's-Eye Maculopathy in a Patient with Lupus",

abstract = "CHIEF COMPLAINT:49 yo male visualizes a “yellow donut hole” in his central vision x one year. He notes impaired night vision and difficulty focusing on individual letters. He denies eye pain, diplopia, headache, photophobia, sensory or motor deficits. This case may have been related to hydroxychloroquine toxicity.DISCUSSION:Bull{\textquoteright}s-eye maculopathy signifies irreversible damage, which may continue to progress months following discontinuing the medication. The American Academy of Ophthalmology recommends: Baseline retinal screening within the first year of treatment and an Annual follow-up screening after 5 years. ",

keywords = "Bull's Eye, Lupus complication, Maculopathy, Ophthalmology",

author = "Kristina Lou and Christopher Forest",

year = "2016",

month = may,

language = "American English",

note = "American Academy of Physician Assistants / 40th Annual PA Conference ; Conference date: 01-05-2016",

}

TY - CONF

T1 - Bull's-Eye Maculopathy in a Patient with Lupus

AU - Lou, Kristina

AU - Forest, Christopher

PY - 2016/5

Y1 - 2016/5

N2 - CHIEF COMPLAINT:49 yo male visualizes a “yellow donut hole” in his central vision x one year. He notes impaired night vision and difficulty focusing on individual letters. He denies eye pain, diplopia, headache, photophobia, sensory or motor deficits. This case may have been related to hydroxychloroquine toxicity.DISCUSSION:Bull’s-eye maculopathy signifies irreversible damage, which may continue to progress months following discontinuing the medication. The American Academy of Ophthalmology recommends: Baseline retinal screening within the first year of treatment and an Annual follow-up screening after 5 years.

AB - CHIEF COMPLAINT:49 yo male visualizes a “yellow donut hole” in his central vision x one year. He notes impaired night vision and difficulty focusing on individual letters. He denies eye pain, diplopia, headache, photophobia, sensory or motor deficits. This case may have been related to hydroxychloroquine toxicity.DISCUSSION:Bull’s-eye maculopathy signifies irreversible damage, which may continue to progress months following discontinuing the medication. The American Academy of Ophthalmology recommends: Baseline retinal screening within the first year of treatment and an Annual follow-up screening after 5 years.

KW - Bull's Eye

KW - Lupus complication

KW - Maculopathy

KW - Ophthalmology

M3 - Presentation

T2 - American Academy of Physician Assistants / 40th Annual PA Conference

Y2 - 1 May 2016

ER -